Exclusive Webinar :Gain complete knowledge about how you can invest in global markets during an insightful webinar on April 16 at 11 am. Register Now!
you are here: HomeNewsBusiness

Coronavirus | Centre may infuse Rs 90,000 crore in gencos: Report

The proposal is under consideration by the finance ministry, but the final draft would require Cabinet approval, a government official said

April 29, 2020 / 03:38 PM IST

The government is considering a Rs 90,000 crore low-cost finance infusion plan for the cash-strapped power sector as generation companies (gencos) seek cash amid the country-wide coronavirus lockdown. The aim is to keep gencos up and running and preventing blackouts.

For this, the power ministry has sought a special window for bonds and also approached agencies like the Employees’ Provident Fund Organisation (EPFO), Life Insurance Corporation (LIC) of India and National Small Savings Fund (NSSF) for funding, The Economic Times reported.

The proposal is under consideration by the Finance Ministry, but the final draft would require Cabinet approval, a government official told the paper.

Moneycontrol could not independently verify the report.

Follow our LIVE Updates on the coronavirus pandemic here

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The loans would be made available to the Power Finance Corporation (PFC) and REC – the sector’s lending institutions. To this end, the ministry has asked for consideration of relaxation of exposure norms so that banks and financial institutions can freely lend to PFC and REC. The entities will forward the benefit to electricity distribution companies (discoms), it added.

“The scheme needs access to cheap funds for which it needs support of the finance ministry. We are hoping it will happen soon. It is a big amount and hence everyone needs to be on board,” the official added.

Follow our full COVID-19 coverage here
Moneycontrol News
first published: Apr 29, 2020 03:37 pm

stay updated

Get Daily News on your Browser
Sections